Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
209M
-
Number of holders
-
55
-
Total 13F shares, excl. options
-
55.9M
-
Shares change
-
-4M
-
Total reported value, excl. options
-
$58.7M
-
Value change
-
-$4.3M
-
Put/Call ratio
-
0.14
-
Number of buys
-
25
-
Number of sells
-
-44
-
Price
-
$1.05
Significant Holders of Invivyd, Inc. - Common Stock (IVVD) as of Q2 2023
82 filings reported holding IVVD - Invivyd, Inc. - Common Stock as of Q2 2023.
Invivyd, Inc. - Common Stock (IVVD) has 55 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 55.9M shares
of 209M outstanding shares and own 26.7% of the company stock.
Largest 10 shareholders include FMR LLC (9.94M shares), M28 Capital Management LP (9.25M shares), Alphabet Inc. (5.68M shares), ORBIMED ADVISORS LLC (5.27M shares), 683 Capital Management, LLC (4M shares), Slate Path Capital LP (3.74M shares), VANGUARD GROUP INC (2.49M shares), MAVERICK CAPITAL LTD (2.34M shares), CITIGROUP INC (2.33M shares), and Bain Capital Life Sciences Investors, LLC (1.94M shares).
This table shows the top 55 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.